Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Infection and CD79B[original query] |
---|
Innate immunity and non-Hodgkin's lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk. PloS one 2012 7 (9): 9. Park SK, Yang JJ, Oh S, Cho LY, Ma SH, Shin A, Ko KP, Park T, Yoo KY, Kang D |
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis. Haematologica 2019 May . Vermaat Joost S, Somers Sebastiaan F, de Wreede Liesbeth C, Kraan Willem, de Groen Ruben A L, Schrader Anne M R, Kerver Emile D, Scheepstra Cornelis G, Beerenschot Henriëtte, Deenik Wendy, Wegman Jurgen, Broers Rianne, de Boer Jan-Paul D, Nijland Marcel, van Wezel Tom, Veelken Hendrik, Spaargaren Marcel, Cleven Arjen H, Kersten Marie José, Pals Steven |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. Haematologica 2020 4 106 (4): 1120-1128. Garcia-Reyero Julia, Martinez Magunacelaya Nerea, Gonzalez de Villambrosia Sonia, Loghavi Sanam, Gomez Mediavilla Angela, Tonda Raul, Beltran Sergi, Gut Marta, Pereña Gonzalez Ainara, d'Ámore Emanuele, Visco Carlo, Khoury Joseph D, Montes-Moreno Santia |
Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. Experimental hematology & oncology 2022 Oct 11 (1): 71. Li Shan-Shan, Zhai Xiao-Hui, Liu Hai-Ling, Liu Ting-Zhi, Cao Tai-Yuan, Chen Dong-Mei, Xiao Le-Xin, Gan Xiao-Qin, Cheng Ke, Hong Wan-Jia, Huang Yan, Lian Yi-Fan, Xiao Ji |
Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement. Frontiers in immunology 2023 9 14 1219167. Hongzhi Geng, Sixun Jia, Ying Zhang, Jiaqi Li, Qin Yang, Liangyu Zeng, Xiangping Zong, Yutong Lu, Shuangzhu Lu, Jin Zhou, Caixia Li, Depei |
- Page last reviewed:Feb 1, 2024
- Content source: